CLDN3 and colorectal carcinoma: CLDN3 is similarly overexpressed at the mRNA level in CRC tumors that belong to the consensus molecular subgroup (CMS)-CMS2 and CMS3, which correspond to a poor prognosis (Tang et al., 2011; Perez et al., 2020).